PO.BCS01.06 · 生物信息与计算
TissueTrek:一个用于探索癌症空间形态学-分子关系的交互式多模态网络平台
TissueTrek: An interactive multimodal web-based platform for exploring spatial morphology-molecular relationships in cancer
作者与单位 Authors & Affiliations
摘要 Abstract
中文摘要
背景:上皮、间质和免疫区室的空间组织在塑造肿瘤行为中发挥着基础作用,然而研究人员和临床医生缺乏能够同时探索形态学、病理组学特征和空间分子测量的可及工具。现有方法通常一次仅检查单一模态,需要专门的专业知识,或提供有限的可解释性。为填补这一空白,我们开发了TissueTrek,一个交互式网络平台,将H&E形态学、定量病理组学、空间基因和蛋白表达以及可解释机器学习(ML)输出整合到一个统一的环境中,可供研究人员、临床医生、学员和患者轻松使用。
方法:该平台基于一个包含57个FFPE三阴性乳腺癌(TNBC)组织芯的GeoMx DSP队列构建。持证病理学家对肿瘤感兴趣区域(ROI)进行注释。提取了三种ROI匹配的模态:来自H&E图像的77个病理组学特征、91个经空间分析且具有生物学相关性的基因,以及570个经空间分析的蛋白。为辅助可解释性,纳入了上游开发的多个ML流程的结果。多种网络技术实现了ROI与其分子、病理组学和模型衍生表征的动态链接,以进行实时探索。
结果:TissueTrek提供了首个ROI解析界面,能够在同一组织背景下同时可视化:(i)空间测量的基因和蛋白表达,(ii)定量病理组学特征,以及(iii)可解释的深度学习和病理组学-ML输出。用户可通过多种特征交互式地进行结果探索,以解读组织ROI背后的生物学。模型输出面板显示这些ROI的可解释图谱,从而能够研究TNBC中原本难以辨别的空间形态学-分子关系。
结论:TissueTrek代表了一种前所未有、完全可解释的空间病理学界面,将形态学、分子和深度学习衍生的见解统一到同一ROI解析环境中。尽管在TNBC中进行了演示,该框架具有可泛化性,能够无缝纳入更多生物标志物、疾病或空间组学技术,使其广泛可及,从计算科学专家到临床医生、学员以及寻求理解自身组织生物学的患者。通过实现对多模态空间生物学的广泛、用户友好的访问,该平台推动计算病理学迈向更透明、更具临床可转化性且可用于教育的数字组织生态系统。该平台将持续以数据和结果进行更新,以更好地服务社区。
查看英文原文 English abstract
Background: The spatial organization of epithelial, stromal, and immune compartments plays a fundamental role in shaping tumor behavior, yet researchers and clinicians lack accessible tools to concurrently explore morphology, pathomic features, and spatial molecular measurements. Existing methods typically examine a single modality at a time, require specialized expertise, or offer limited interpretability. To address this gap, we developed TissueTrek, an interactive web-based platform that integrates H&E morphology, quantitative pathomics, spatial gene and protein expression, and explainable Machine Learning(ML) outputs into a unified environment that can be easily used by researchers, clinicians, trainees, and patients alike.
Methods: The platform was built using a GeoMx DSP cohort of 57 FFPE triple-negative breast cancer (TNBC) tissue cores. Board-certified pathologists annotated tumor regions of interest (ROIs). Three ROI-matched modalities were extracted: 77 pathomic features from H&E images, 91 spatially profiled and biologically relevant genes, and 570 spatially profiled proteins. The results from several ML pipelines developed upstream were incorporated to aid interpretability. Several web-based technologies enabled dynamic linking of ROIs with their molecular, pathomic, and model-derived representations for real-time exploration.
Results: TissueTrek provides the first ROI-resolved interface enabling simultaneous visualization of (i) spatially measured gene and protein expression, (ii) quantitative pathomic features, and (iii) interpretable deep-learning and pathomics-ML outputs within the same tissue context. Users can interactively conduct exploration of results through multiple features to decipher the biology underlying the tissue ROIs. The Model Output panel displays interpretable maps of these ROIs, enabling the study of spatial morphology-molecular relationships in TNBC that are otherwise difficult to discern.
Conclusions: TissueTrek represents a first-of-its-kind, fully interpretable spatial pathology interface that unifies morphologic, molecular, and deep-learning-derived insights into the same ROI-resolved environment. Although demonstrated in TNBC, the framework is generalizable and is capable of seamlessly incorporating additional biomarkers, diseases, or spatial-omics technologies, making it widely accessible, from expert computational scientists to clinicians, trainees, and patients seeking to understand their tissue biology. By enabling broad, user-friendly access to multimodal spatial biology, the platform advances computational pathology toward more transparent, clinically translatable, and educationally usable digital tissue ecosystem. This platform will be updated with the data and results constantly to serve the community better.
利益披露 Disclosure
V. R. Rao, None..
M. E. Barajas, None..
C. C. Black, None..
M. K. Sadanandappa, None..
S. M. Palisoul, None..
A. A. Workman, None..
T. A. MacKenzie, None..
L. J. Vaickus, None..
M. D. Chamberlin, None..
G. J. Zanazzi, None..
S. S. Sukhadia, None.